Citius Oncology Inc.CTORNASDAQ
Loading
Year-over-year SG&A expense growth
Latest
87.47%
↑ 139% vs avg
Percentile
P79
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
36.59%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 87.47% |
| Q3 2025 | -9.27% |
| Q2 2025 | -7.51% |
| Q1 2025 | -15.57% |
| Q4 2024 | -4.51% |
| Q3 2024 | 53.62% |
| Q2 2024 | 4.63% |
| Q1 2024 | -2.69% |
| Q4 2023 | -11.74% |
| Q3 2023 | 188.60% |
| Q2 2023 | -27.74% |
| Q1 2023 | 141.07% |
| Q4 2022 | -64.36% |
| Q3 2022 | 216.85% |
| Q2 2022 | 0.00% |